Peter Johann
InvestorManaging General Partner at NGN Capital
Find your path to Peter
Sign up to see every warm intro you have to Peter
- Paths you didn't know you had: your email and LinkedIn already hold routes to Peter. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Managing General Partner at NGN Capital with a background in biotech and pharmaceutical business development, having previously held senior corporate development, licensing, and marketing roles at Boehringer Ingelheim, F. Hoffmann-La Roche, and Boehringer Mannheim. He holds a Ph.D. from the Technical University Munich and serves on several life sciences company boards including Exosome Diagnostics and Vivaldi Biosciences.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
Cerapedics, Inc.Endosense SAExosome Diagnostics Inc.Horizon Pharma IncJerini AGMicromet Inc.NaniRx TherapeuticsNoxxon Pharma AGResverlogix Corp.Santhera Pharmaceuticals AGVivaldi Biosciences, Inc.Zenith Epigenetics Inc.
Per the firm's website.
Colleagues at NGN Capital
Frequently asked questions
- Who is Peter Johann?
- Managing General Partner at NGN Capital with a background in biotech and pharmaceutical business development, having previously held senior corporate development, licensing, and marketing roles at Boehringer Ingelheim, F. Hoffmann-La Roche, and Boehringer Mannheim. He holds a Ph.D. from the Technical University Munich and serves on several life sciences company boards including Exosome Diagnostics and Vivaldi Biosciences.
- Where does Peter Johann work?
- Peter Johann is Managing General Partner at NGN Capital.
- What does Peter Johann invest in?
- Peter Johann invests in Biotech.
- What boards does Peter Johann sit on?
- Peter Johann holds tracked board seats at Cerapedics, Inc., Endosense SA, Exosome Diagnostics Inc., Horizon Pharma Inc, Jerini AG, Micromet Inc., NaniRx Therapeutics, Noxxon Pharma AG, Resverlogix Corp., Santhera Pharmaceuticals AG.
About this profile. Compiled from public sources — NGN Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights



